scholarly journals Health Systems Research Consortia and the Promotion of Health Equity in Low and Middle-Income Countries

2016 ◽  
Vol 16 (3) ◽  
pp. 148-157 ◽  
Author(s):  
Bridget Pratt ◽  
Katharine A. Allen ◽  
Adnan A. Hyder
2014 ◽  
Vol 9 (9) ◽  
pp. 1008-1022 ◽  
Author(s):  
Adnan A. Hyder ◽  
Bridget Pratt ◽  
Joseph Ali ◽  
Nancy Kass ◽  
Nelson Sewankambo

2014 ◽  
Vol 14 (2) ◽  
pp. 28-37 ◽  
Author(s):  
Adnan A. Hyder ◽  
Abbas Rattani ◽  
Carleigh Krubiner ◽  
Abdulgafoor M. Bachani ◽  
Nhan T. Tran

Author(s):  
Bridget Pratt ◽  
Adnan A. Hyder

This chapter focuses on the ethics of health systems research. It first explores the extent to which traditional bioethics principles—respect for persons, beneficence, and justice—are relevant to this growing field. It then demonstrates that, while these principles are pertinent to health systems research, they can be interpreted and applied differently relative to biomedical research. Upholding justice, for example, entails ensuring that projects not only fairly distribute benefits and burdens, but also specifically contribute to advancing global health justice. The chapter then argues that health systems research may further require the application of additional core ethical commitments to consider the full range of ethical issues arising in the field. Ethical commitments to public engagement, collaboration, and sustainability, which have been identified as core commitments of the field of health systems ethics, are suggested as necessary for responsible ethical oversight of health systems research. While the ethical issues discussed are globally relevant, the chapter assumes a deliberate (though not exclusive) focus on low- and middle-income countries (LMICs).


2019 ◽  
Vol 34 (Supplement_3) ◽  
pp. iii1-iii3 ◽  
Author(s):  
Sachiko Ozawa ◽  
Raja Shankar ◽  
Christine Leopold ◽  
Samuel Orubu

Abstract Nearly 2 billion people globally have no access to essential medicines. This means essential medicines are unavailable, unaffordable, inaccessible, unacceptable or of low quality for more than a quarter of the population worldwide. This supplement demonstrates the implications of poor medicine access and highlights recent innovations to improve access to essential medicines by presenting new research findings from low- and middle-income countries (LMICs). These studies answer key questions such as: Can performance-based financing improve availability of essential medicines? How affordable are cardiovascular treatments for children? Which countries’ legal frameworks promote universal access to medicines? How appropriately are people using medicines? Do poor-quality medicines impact equity? Answers to these questions are important as essential medicines are vital to the Sustainable Development Goals and are central to the goal of achieving Universal Health Coverage. Access to affordable, quality-assured essential medicines is crucial to reducing the financial burden of care, preventing greater pain and suffering, shortening the duration of illness, and averting needless disabilities and deaths worldwide. This supplement was organized by the Medicines in Health Systems Thematic Working Group of Health Systems Global, a membership organization dedicated to promoting health systems research and knowledge translation. The five studies in the supplement further our understanding by showcasing recent successes and challenges of improving access to quality-assured medicines through health systems in LMICs.


Sign in / Sign up

Export Citation Format

Share Document